Byoung S. Kwon,Young Ho Kim,Mun Ki Kim,Kwang Hee Kim,You Hyun Kang
申请号：
US16715695
公开号：
US20200188437A1
申请日:
2019.12.16
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to a pharmaceutical composition for preventing or treating cancer comprising cancer antigen-specific cytotoxic T cells； the pharmaceutical composition comprises about 7×106 cells/mL or more, and of the about 7×106 cells/mL, about 90% or more are CD8+ T cells.
